A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

VITROS Immunodiagnostic Products NT-proBNP II

Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo

A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus

Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to

Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors

Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation

A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation

A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies

Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe Gout

A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Participants With Active Systemic Lupus Erythematosus (SLE)

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease